Status:

COMPLETED

Misoprostol Dosing in BMI Greater Than 30

Lead Sponsor:

University of Texas at Austin

Conditions:

Pregnancy Related

Obesity

Eligibility:

FEMALE

18+ years

Phase:

PHASE4

Brief Summary

The investigators are performing a randomized controlled-trial investigating if 50mcg (compared to 25 mcg) of vaginal misoprostol reduces the time from induction start to delivery in obese women.

Detailed Description

As of 2019, almost 1 in 4 women in the United States had their labor induced with almost 9 in 10 women requiring different methods to prepare their cervix for induction. There have been several resear...

Eligibility Criteria

Inclusion

  • Singleton gestation
  • Age 18 years or older
  • Gestational age \>= 36 weeks
  • BMI \>= 30 kg/m2 at time of labor induction
  • Cephalic presentation (including successful external cephalic version)
  • Cervical dilation \<= 3cm
  • Intent to proceed with cervical ripening

Exclusion

  • Contraindication to vaginal delivery (placenta previa, vasa previa, prior classical cesarean, non-vertex presentation, etc.)
  • Contraindication to prostaglandin administration (significant allergy, prior cesarean delivery, etc.)
  • Multiple gestations
  • Gestational age \< 36 weeks
  • Non-reassuring fetal heart tracing
  • Evidence of clinical chorioamnionitis
  • Significant vaginal bleeding with concern for abruption
  • Prior cesarean delivery or uterine surgery
  • Major fetal anomaly or demise
  • Cervix \>3cm
  • No intention to proceed with cervical ripening (not indicated, favorable bishop score, plan for Oxytocin administration, etc.)
  • Uterine tachysystole (defined as \>= 5 contractions within a 10m period)
  • Fetal Growth Restriction (EFW \<= 5% or elevated/absent/reversed Umbilical Artery dopplers)
  • Inability to give consent (inability to read/write in English or Spanish)

Key Trial Info

Start Date :

June 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 17 2023

Estimated Enrollment :

180 Patients enrolled

Trial Details

Trial ID

NCT05262738

Start Date

June 1 2022

End Date

July 17 2023

Last Update

July 3 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Texas at Austin Dell Medical School, Department of Women's Health

Austin, Texas, United States, 78705